Star Imaging and Path Lab Limited has announced its empanelment with the Indian National Science Academy (INSA) for providing comprehensive medical diagnostic and laboratory services. The company disclosed this development on January 21, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Empanelment Details

The empanelment arrangement encompasses several key aspects that position the company as a healthcare service provider for INSA's stakeholders:

Service Coverage and Benefits

Under this empanelment, Star Imaging and Path Lab Limited will provide medical treatment services focusing on diagnosis and laboratory testing. The arrangement allows INSA personnel and their families to access the company's healthcare services at standardized government-approved rates, ensuring cost-effective medical care for the beneficiaries.

The five-year validity period provides a stable business opportunity for the company while ensuring continuity of healthcare services for INSA stakeholders. This long-term arrangement reflects confidence in the company's service capabilities and infrastructure.

Regulatory Compliance and Business Impact

The company has emphasized that this empanelment represents business conducted in the ordinary course and does not constitute a material event impacting its financial position. The disclosure has been made as part of regulatory compliance requirements and to maintain transparency with stakeholders.

Company Secretary and Compliance Officer Md Shadab Khan signed the regulatory filing, ensuring proper documentation and compliance with listing obligations. This empanelment adds to the company's portfolio of institutional healthcare partnerships and demonstrates its capability to serve government and academic institutions.

Star Imaging and Path Lab Limited has announced that its request to provide medical services on a credit and cashless basis to the High Court of Delhi has been accepted by the competent authority. The arrangement covers all serving officers and officials of the High Court of Delhi, including their dependent family members.

Service Arrangement Details

The medical services contract encompasses several key parameters that define the scope and nature of the arrangement:

Business Impact and Compliance

The company has clarified that this arrangement falls within its ordinary course of business operations. Star Imaging and Path Lab Limited stated that the contract does not have any material financial impact on the company's operations. The arrangement is not classified as a related party transaction, ensuring compliance with regulatory requirements.

Regulatory Framework

The medical services will be provided in accordance with CGHS guidelines and rates, ensuring standardized healthcare delivery. The arrangement will be governed by:

• Applicable laws and regulations
• Central Government Health Scheme guidelines
• Company's internal policies and procedures

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's commitment to transparency and regulatory compliance. The announcement was signed by Md Shadab Khan, Company Secretary and Compliance Officer, on January 21st, 2026.